Which drug works best for a deadly kidney complication?
NCT ID NCT07460908
First seen Mar 14, 2026 · Last updated May 22, 2026 · Updated 12 times
Summary
This study tested two medicines, terlipressin and octreotide, in 60 adults with hepatorenal syndrome—a rapid kidney failure linked to severe liver disease. The goal was to see which drug better improves kidney function within 48 hours. Results could help doctors choose the most effective treatment for this life-threatening condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATORENAL SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Lahore General Hospital, Lahore
Lahore, Punjab Province, 54000, Pakistan
Conditions
Explore the condition pages connected to this study.